Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro

The Journal of Infectious Diseases
A GruberReinhard Würzner

Abstract

Previously, it has been shown that human immunodeficiency virus (HIV)-1 envelope proteins gp160 and gp41 bind to Candida albicans. Whether this interaction affects candidal virulence in vitro was investigated. HIV-1 gp160 or gp120 treatment of C. albicans significantly altered neither growth nor phospholipase activity of the fungus. However, treatment of C. albicans with gp160, but not with gp120, led to an elevation of free and cell-bound aspartate proteinase. In addition, culture supernatants obtained from C. albicans treated with gp160 or gp41, but not with gp120, showed a strong increase in proteinase activity. Finally, C. albicans viable yeast cells treated with gp160 or gp41 and serum were phagocytosed by polymorphonuclear leukocytes to a lesser extent than was C. albicans treated with gp120 and serum or serum alone. These findings suggest that the interaction between HIV-1 gp160 and C. albicans may promote the virulence of C. albicans in HIV-1-positive patients.

Citations

Feb 19, 2003·FEMS Immunology and Medical Microbiology·Cornelia Lass-FlörlReinhard Würzner
May 23, 2002·Antimicrobial Agents and Chemotherapy·Markus NaglReinhard Würzner
Oct 19, 2004·Clinical Microbiology Reviews·Louis de RepentignyPaul Jolicoeur
Sep 11, 2003·Microbiology and Molecular Biology Reviews : MMBR·Julian R NaglikBernhard Hube
Sep 7, 2013·PloS One·Christian Rodriguez RodriguesJorge Geffner
Feb 26, 2010·World Journal of Biological Chemistry·André Luis Souza Dos Santos
Feb 6, 2007·International Journal of Antimicrobial Agents·Susanne PerkhoferCornelia Lass-Flörl
Aug 19, 2008·Mycoses·Cornelia SpethCornelia Lass-Flörl
Apr 22, 2008·Mycoses·Barbara FalkensammerReinhard Würzner
Oct 4, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Xiaoxu LiQianming Chen
Sep 15, 2005·International Journal of Antimicrobial Agents·A MayrC Lass-Flörl
Mar 15, 2003·International Journal of Medical Microbiology : IJMM·Till TriebelReinhard Würzner
May 29, 2003·FEMS Immunology and Medical Microbiology·Andreas GruberReinhard Würzner
Sep 18, 2003·FEMS Immunology and Medical Microbiology·Edja Maria Melo de Brito CostaRosangela Maria de Araújo Soares
Apr 14, 2004·Mycoses·Cornelia SpethReinhard Würzner
May 5, 2006·Advances in Dental Research·S J Challacombe, J R Naglik
Mar 10, 2001·Journal of Acquired Immune Deficiency Syndromes : JAIDS·L MillonD Meillet
Apr 14, 1999·Antimicrobial Agents and Chemotherapy·P DizI Otero
Apr 3, 2021·Frontiers in Cellular and Infection Microbiology·Stephan Alberto Machado de OliveiraAnamelia Lorenzetti Bocca
Apr 16, 1999·Journal of Clinical Microbiology·F de BernardisA Cassone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.